AMSAR: A Pioneering Brand Spearheading the Growth of Indian Herbal Sector

Dr. Vikram Andrew Naharwar , CEO

Dr. Vikram Andrew Naharwar

CEO

Medicinal plants, for centuries, have been widely used as a primary healthcare practice for treating various acute diseases. Over the last decade, the growing awareness regarding the side effects of allopathic medicines has led to a growing inclination towards alternative medicines, such as Ayurveda, Naturopathy, Homeopathy, and Herbal medicine, which, in turn, has helped the herbal extracts manufacturing sector experience massive growth. Being known as the global Ayurveda hub, India is blessed with a rich diversity of medicinal plants and is home to numerous Ayurvedic companies. The Indian herbal Extract industry is estimated to reach $2.6 billion by 2027 at a staggering CAGR of 11.7 percent.

Founded in 1963 by two scientists, Amsar is a Goa-based leading Herbal extract, nutraceutical, and natural cosmetic manufacturer that employs the highest levels of technical expertise, advanced manufacturing, and validation technologies in a transparent, dedicated, and visionary environment to offer best-quality deliverables to its customers. As the first organization to manufacture full-spectrum standardized extracts, the company has been at the forefront of the Indian herbal industry for over six decades while representing a unique blend of traditional knowledge and modern science. Amsar, a family-owned business, is currently led by the third-generation technocrat in the family, Dr. Vikram Andrew Naharwar.

A Major Focus on Product Quality

Coming to product portfolio, Amsar manufactures a wide range of products under categories, such as Herbal extracts, cosmetic extracts, natural colors, aquaculture solutions, and natural sweeteners. According to Dr. Naharwar, “The Indian herbal market today is marred with adulteration, with companies using a lot of herb substitution in place of the real ones. A majority of the companies don’t even have their own laboratories or testing facilities. So you don’t have much idea whether the extract that you are getting is authentic or not. Several companies nowadays are involved in the substitution of herbs with the same class of compounds, which impacts the efficacy and safety of extracts.

When it comes to product quality, Amsar, as an organization, has a no-compromise policy and mitigates the quality challenges present in the market by getting the raw herbs directly from the ethnic tribal communities from the forest, which, even though a bit expensive, ensures the highest product quality. In other words, it also cuts the middlemen out of the picture as the business is done directly with the sellers, which also ensures a sustainable livelihood for the communities that get the actual value of the produce rather than a fraction.

Stringent Quality Checks to Ensure Customer Satisfaction

Once received, the raw materials then go through a series of stringent quality checks to ensure the best quality deliverables. Dr. Naharwar is also a consultant and an expert advisor to the American Herbal Pharmacopoeia committee. At Amsar, every batch of raw material that comes for production is tested microscopically & macroscopically. Amsar provides voucher samples of plants to AHP.

Amsar has been at the forefront of the Indian herbal industry for over six decades while representing a unique blend of traditional knowledge & modern science

Dr. Vikram Andrew Naharwar , CEO

The raw materials initially go through microscopic and macroscopic analysis, where parameters, such as authenticity, maturity, and right chemical profile, are checked. The materials then go through HPTLC analysis, which further ensures the plant's authenticity by analyzing whether the factors or contents guaranteed are present in the extract or not. The company also does microbiology for pharma-standard bacterial profiles to ensure that the plants don't have any risks of contamination. When it comes to exports, every single batch of extracts at Amsar is tested for any contaminants by EU-accredited third-party laboratories.

The Only Company to Use Biotope Ingredients

One of the major factors that make Amsar stand out from the rest of its peers in the market is the diverse range of exceptionally unique Biotope herbs offered by the company. Amsar is the only company in the country to use Biotope ingredients and herbs. “As wild-crafted herbs are pretty expensive and there is a lack of the same, herbs are cultivated all across the country now. However, cultivating them in different geographies rather than the native geography results in the herbs losing their efficacy as prescribed in Ayurveda. At Amsar, we buy the herbs exactly from the places mentioned in the ancient Ayurvedic texts, which ensures a proper growing environment for the herbs as well as the best quality products”, explains Dr. Naharwar.

Fermented Plant Extracts for Cosmetic Extraction

When it comes to cosmetics extracts, the conventional extraction process requires water and solvents. However, the solvents used, such as Benzene, Acetone, Ethyl acetate, and so on, are toxic compounds, and on use, the residues in them cause major skin issues. Around two years ago, Amsar also ventured into fermented extract manufacturing, which has become extremely popular in terms of product quality and aroma. However, instead of following the conventional process, we produce fermented plant extracts using the natural bacteria found in food sources. These bacteria have the advantage of digesting the sugar and creating an environment for extraction that produces the most authentic and safest form of extract while retaining the natural aroma and colors, which is not possible through solvent extraction.

Torchbearer of R&D Operations

One of the biggest strengths of Amsar is its extensive R&D operations. The company has been doing R&D since 1979 and was also the first organization in India to be recognized by DSIR in 1981. The company works on development, safety, efficacy, and clinical & preclinical studies regularly. In a country where less than one percent of all companies in the traditional medicine sector have active R&D programs with an average R&D expenditure being 0.5 percent of the overall revenue, Amsar has been a torchbearer for the last 45 years.

The company has more than 30 published papers as well as several patents in therapeutic areas, where there is yet no cure available in modern medicine. “Our family has a history of scientists. Even my grandfather, who started this company, was a scientist, who completed his studies at Cambridge, England, and worked for a few MNCs before returning and starting this company. Scientists play a major role in Amsar, without whom, we wouldn't be where we are. One of the major surprising factors about Amsar is that the company doesn't have a sales or marketing team. We have survived over 61 years without sales and marketing because of the product quality that comes through extensive R&D”, shares Dr. Naharwar.

Future Roadmap

Coming to the future roadmap, Amsar is gradually transitioning to fermented extracts. It also has its own line of products, such as medicinal products, formulas, and cosmetics. In terms of growth, instead of focusing on overall revenue growth, Amsar is primarily focused on ensuring customer satisfaction through best quality products. “Growth comes with serious risks in terms of ethics. Sometimes, you will have no choice but to compromise in case you have huge a demand and you can't meet that. We derive growth from customer satisfaction. What makes us truly happy and satisfied is when people with serious chronic health issues get better by using our product”, Dr. Naharwar signs off.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.